NMPA Approval

Ursodeoxycholic Acid Oral Suspension

Approval Number

国药准字HJ20240072

Registration Date

July 16, 2024

Drug Information

Generic Name

熊去氧胆酸口服混悬液

Dosage Form

口服混悬剂

Strength

250ml：12.5g

Drug Type

化学药品

Registration Date

July 16, 2024

Expiry Date

July 15, 2029

Company Address

Leinenweberstraße 5 79108 Freiburg, Germany

Company Address

Brühlstrasse 50 4107 Ettingen, Switzerland

Empowering clinical research with data-driven insights and AI-powered tools.

熊去氧胆酸口服混悬液 - NMPA 批准文号 | MedPath